AMGN

2026Q1AMC

Amgen Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-04-30 · Fiscal end 2026-03-31 · Features as of 2026-04-30

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS4.77
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.0%
IV front—
P/C full—
P/C front—
Features as of2026-04-30

Run-up

Close—
Ret 5d-0.7%
Ret 10d-0.9%
Ret 20d-2.0%
Ret 30d-1.5%

Post-Earnings Data

Results & reaction

Print

Actual EPS
5.15Beat
Estimated EPS4.77
Actual revenue
8.6B
Surprise %+8.0%
Beat / missBeat
Beat streak 44
Beat streak 87

Reaction

1-day stock reaction-0.8%
Implied vs actual

Implied 2.0%Actual 4.0%

Gap reaction-4.0%
Day result-4.7%
Next-day upNo
Realized / IV1.96×

Post tape

Post 5d+0.6%
Post 10d-1.1%
Post volume3.8M
Vol ×10d1.51×
Vol ×20d1.56×
Post range3.7%